Breaking Down Neurocrine Biosciences: 12 Analysts Share Their Views

Market Impact

Benzinga Insights

September 5, 2025

Benzinga

Latest Ratings for NBIX

Date	Firm	Action	From	To
Mar 2022	Piper Sandler	Downgrades	Overweight	Neutral
Feb 2022	Goldman Sachs	Upgrades	Neutral	Buy
Feb 2022	Morgan Stanley	Maintains		Equal-Weight

View More Analyst Ratings for NBIX

View the Latest Analyst Ratings

Market Impact

Howard Lutnick Says Elon Musk Got DOGE 'Backward,' Focused On Firing Instead Of Cutting Government Waste

September 13, 2025

Benzinga

Market Impact

Hims & Hers Faces FDA Heat As Commissioner Martin Makary Calls Out Super Bowl Ad For Hiding Drug Risks

September 13, 2025

Benzinga

Market Impact

Winklevoss Twins' Gemini Hits $4.4 Billion Valuation In Strong Nasdaq Debut

September 13, 2025

Benzinga

Market Impact

Tuya Accelerates AI Strategy

September 5, 2025

Benzinga

Market Impact

BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data

September 5, 2025

Benzinga

Market Impact

This Twilio Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

September 5, 2025

Benzinga

Markets

Stocks Slide as Trump Meets Putin | Closing Bell

August 15, 2025

Bloomberg

Equities

Stocks Supported by Fed Rate Cut Speculation and Strength in Chip Makers

August 11, 2025

Barchart

Markets

US Attacks Three Nuclear Sites in Iran, Widening Conflict

June 22, 2025

Bloomberg

Enjoy premium content in your inbox.

You're in! Check your email to learn more.

Oops! Something went wrong while submitting the form.

Breaking Down Neurocrine Biosciences: 12 Analysts Share Their Views

Latest Ratings for NBIX

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.

News

Tools

More

Follow